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R
 
ecent technological advances have shed unexpected
light on the CD8
 
1
 
 T cell responses to pathogens and
have raised concerns that a familiar quantitative assay is
wrong. The most exciting of the new advances is the
MHC tetramer. Ever since T cells were first identified,
there have been attempts to show that they can be individ-
ually identified by the specificity of their antigen binding
properties. The early quest failed because the ligand was
not known to be an MHC–peptide complex. When the T
cell receptor was eventually identified, it was ironic that it
had still not been shown to bind anything. However, stud-
ies with purified receptors and complexes of antigenic pep-
tide and MHC showed that they did bind specifically, but
with low affinity and fast off-rates (1). It is now argued that
during T cell recognition, the low affinity and fast off-rate
are necessary to enable serial contact of each TCR mole-
cule with multiple MHC–peptide ligands (2). Such charac-
teristics were assumed to be too unfavorable for direct
staining of T cells.
Using purified I-E
 
k
 
 molecules bound to a pigeon cyto-
chrome c peptide, Davis and Altman prepared a tetrameric
complex (3). They used the enzyme BirA, which specifi-
cally biotinylates a lysine residue within a 13–amino acid
recognition sequence. The BirA recognition tag was engi-
neered onto the COOH terminus of the extracellular do-
main of one chain of the MHC molecule, allowing it to be
enzymatically labeled with biotin and bound to streptavi-
din. As the latter has four biotin binding sites, this pro-
duced tetramers of MHC molecules that bound to cells dis-
playing the appropriate TCR. These multimeric MHC
ligands had a far greater avidity for the T cells than the sum
of the individual monomeric affinities. This binding can be
easily detected by FACS
 
Ò
 
 (Becton Dickinson, Mountain
View, CA) analysis if a fluorochrome-labeled streptavidin
reagent is used. In collaboration with Bell et al. (4) who
had folded HLA B molecules for crystallization, the
method was then applied to HLA class I molecules (5).
Modeling of HLA B8 with streptavidin (Fig. 1) from
known coordinates reveals a flexible 12–amino acid tail at
the COOH terminus of the heavy chain separating the 
 
a
 
3
domain from the biotin by up to 30 Å. Phycoerythrin, the
most commonly used fluorochrome, is quite large and is
likely to interfere with access of one HLA peptide with the
TCR (Fig. 1). Therefore, much of the binding is likely to
be trimeric, although tetrameric binding could be possible
when the smaller molecule fluorescein is used to label com-
plexes.
Tetrameric complexes of HLA A2 were made with
epitope peptides from HIV 
 
gag
 
 and 
 
pol
 
, and these were
shown to bind to appropriate T cell clones and T cells from
peripheral blood of HIV infected patients (5). The numbers
of blood T cells stained, up to 2% of CD8
 
1
 
 T cells, seemed
high compared with precursor estimates made using limit-
ing dilution assays (LDAs) in similar patients of 1/4,000–1/
20,000 (6). However, the higher figures were in line with
estimates made by analysis of direct cytotoxicity assays (7)
and by TCR transcript quantitation for immunodominant
CTL clones (8, 9). The message, now amply confirmed,
was that persisting virus infection maintained a very strong
CTL response. For persistent HIV infection, the range is
commonly 0.1–2% of CD8
 
1
 
 T cells. In persistent simian
immunodeficiency virus infection in macaques, Kuroda et al.
(10) show that epitope-specific T cells can account for as
many 10% of CD8
 
1
 
 T cells in the blood. These numbers
are reminiscent of the expanded T cell clones bearing par-
ticular V
 
b
 
 chains reported by this group (11). Even larger
expansions of CD8
 
1
 
 T cells carrying oligoclonal T cell re-
ceptors have been reported by Pantaleo et al. in acute HIV
infection (12). In acute infections, these T cell expansions
are relatively short lived and decline to lower levels after
the virus load falls to a steady state. Ogg et al. have shown
in persistently HIV-infected persons that the level of tet-
ramer staining of HIV-specific CD8
 
1
 
 T cells correlates in-
versely with RNA virus load (13). The circulating acti-
vated effector T cells could be controlling virus-infected
cells by direct lysis and/or release of cytokines and
chemokines.
Recently, three papers have examined the CTL response
to acute lymphocytic choriomeningitis virus (LCMV) in-
fection. Butz and Bevan (14) measured the numbers of in-
terferon-producing CD8 T cells after stimulation with
epitope peptides, treatment with brefeldin A, permeabiliza-
tion, and intracellular staining with anti–IFN-
 
g
 
. They
showed that nearly all of the CD8
 
1
 
 T cell expansion in the
spleens of acutely infected mice resulted from growth of
antigen-specific T cells; over a quarter of all CD8
 
1
 
 spleen
cells at the peak response responded to the three immu-
nodominant LCMV peptides in C57/B6 mice. These data
were backed up by experiments where known numbers of
TCR transgenic T cells were transferred into mice and
then expanded by infection of the host. Murali-Krishna et al.
(15) found similar expansions using H-2 class I tetramers
constructed with immunodominant epitope peptides. Over
50% of splenic CD8
 
1
 
 cells were antigen specific in acutely
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LCMV-infected BALB/c and C57BL/6 mice; these T cells
were specific for one epitope in the former mouse strain
and split unevenly between four epitopes in the latter.
When these cells were sorted, almost all made IFN-
 
g
 
 in
ELIspot assay, and killing of target cells was greatly en-
riched. The response peaked at day 8, but high levels (up to
10%) of tetramer staining cells were still detectable after a
year; the strength of these responses followed the known
hierarchy of immunodominance. Gallimore et al. (16) also
found large-sized expansions of antigen-specific T cells in
acute LCMV infection. Using different doses of a rapidly
replicating strain of LCMV, it was shown that the size of
the antigen-specific CD8
 
1
 
 T cell expansion was deter-
mined by the antigen load alone. In all of these experi-
ments, the acute LCMV-specific response is so large that
there is no need to invoke bystander effects (17); Butz and
Bevan (14) showed that adoptively transferred CD8
 
1
 
 TCR
transgenic T cells for an ovalbumin epitope did not expand
on LCMV infection.
In acute infectious mononucleosis in humans, caused by
infection with EBV, Callan et al. (18) found that 20 of 21
patients showed expansions of T cells with restricted TCR
expression, detected by monoclonal antibodies specific for
TCR V
 
b
 
 segments. These numbers returned to normal in
the months after recovery. Now Callan et al. (19) have
shown, using HLA A2 and B8 tetramers, that between 7
and 44% of blood CD8
 
1
 
 T cells are EBV specific in this
acute infection. As found in acute LCMV infection, the to-
tal number of CD8
 
1
 
 T cells is greatly increased, almost en-
tirely by antigen-specific cells. The numbers decline
slowly, reaching a baseline only after 
 
.
 
6 mo. Interestingly,
these responses were directed against EBV lytic cycle
epitopes, rather than the more familiar latent epitopes ex-
pressed on B lymphoblastoid cell lines. The latter CTL re-
sponses were much smaller. In chronically infected persons,
up to 2% of circulating CD8
 
1
 
 T cells are directed against
lytic epitopes, implying continuing turnover of the virus in
infected epithelial cells. These numbers are similar to the
number of HIV-specific CD8
 
1
 
 T cells found in many per-
sons infected with HIV (5).
In acute 
 
Listeria
 
 infection in mice, Busch et al. (20) have
followed the CTL response to four epitopes in primary and
secondary infection. The four responses to 
 
Listeria
 
 showed
similar kinetics in the primary and in the secondary infec-
tions. One unique observation in this study was that CD8
 
1
 
T cells continued to expand for a short time after the in-
fecting microorganism had disappeared. In this study and
that of Butz and Bevan (14), the issue of immunodomi-
nance was addressed. The previously defined hierarchy of
immunodominant epitopes in memory CTL responses was
matched by the number of responding cells in the acute in-
fection. Thus, it appears that immunodominance is set in
the acute infection, provided the acutely activated T cells
do not burn out. Gallimore et al. (16) showed that with
very high doses of infection with LCMV DOCILE, the
previously described clonal exhaustion was accompanied by
loss of tetramer-binding T cells. Why certain responses
dominate in the acute phase is not clear; it may reflect the
quantity of peptide on the infected cell surface, but the
number of naive CTLs before infection may also be highly
relevant. The binding affinity of the TCR to the peptide–
MHC complex may also contribute in a major way to the
clonal burst size.
Figure 1. Model of HLA B8–peptide tetramer. Top, the complex
without the fluorochrome, bottom, phycoerythrin bound to the streptavi-
din. Light blue, streptavidin; dark blue, B8 heavy chain; intermediate blue,
beta-2 microglobulin; purple, the peptide; red, phycoerythrin. The phyco-
erythrin is represented by the crystallographically determined structure,
but in its biologically active form can exist as an even larger trimer of this
structure. The potential extended length between the biotin molecule
and the a3 domain is 30Å. 
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All of these studies show that the acute CD8
 
1
 
 T cell re-
sponse is far greater than generally realized previously, al-
though these results were predicted by the findings of ex-
pansions of T cells with restricted TCR usage in acute
infections with influenza virus, HIV, simian immunodefi-
ciency virus, and EBV (11, 12, 19, 21). Large proliferations
of CD8
 
1
 
 T cells in acute infections had also been noted
previously, but because of the LDA results it was thought
that there must be a large bystander effect (22). In these re-
cent studies with tetramers and antigen-stimulated cytokine
staining, the expansions can be wholly accounted for by
antigen-specific T cells; the possible role of bystander acti-
vation in maintaining T cell memory may have to be re-
thought.
The size of the CD8
 
1
 
 T cell response in acute virus in-
fections is impressive. It is possible that the examples cho-
sen represent one end of a spectrum. In the infections so far
studied, the infection is widespread and not localized. In
contrast, the immune response to lower respiratory tract in-
fluenza infection in mice is maximal in the paratracheal
lymph nodes (21) and the size of the splenic T cell response
may not be so great. The effect of virus dose shown by
Gallimore et al. (16) may also mean that the response is
more moderate in less severe infections. For example,
many acute EBV infections are subclinical and it seems un-
likely that these too will evoke such massive CTL re-
sponses.
The growth of antigen-specific T cells in vivo is impres-
sive. In the murine LCMV infections, the peak rate of divi-
sion was calculated to be 2–3/day, similar to the rapid
growth of B cells in germinal centers (14, 15). In humans,
the exact timing of any natural primary infection is hard to
determine but the total number of antigen-specific T cells
at the peak response is enormous; if the T cells are distrib-
uted evenly throughout the body, 40% of peripheral blood
CD8
 
1
 
 cells means 4 
 
3 
 
10
 
10
 
 in total. Even a more conserva-
tive estimate of 4 
 
3 
 
10
 
9
 
 cells would require 32 divisions, if
derived from a single clone as some of the TCR V
 
b
 
 expan-
sion data imply (12, 18). Most responses are probably oli-
goclonal, but would still need 
 
.
 
25 divisions. Given the
difficulty in eliciting primary CTL responses in vitro, this is
remarkable. We still have much to learn about reproducing
in vivo responses in vitro.
The MHC class I tetramer technique appears to be ex-
quisitely antigen specific and highly sensitive. Staining of T
cell clones shows no cross-reactions so far. The method
easily stains large numbers and can also detect rare cells;
FACS
 
Ò
 
 analysis of PBMCs is sensitive down to 0.02%.
Dunbar et al. (23) found that sorted rare cells showed the
correct antigen specificity in an IFN-
 
g
 
 ELIspot assay (24).
The sorted cells could be grown as clones and they showed
the expected lytic activity. Remarkably few false positive
and negative results have been found so far.
Where does MHC tetramer technology leave other
techniques of detecting antigen-specific CD8
 
1
 
 T cells? The
intracellular cytokine staining of epitope-stimulated T cells
gives similar results (15). The complication of making the
tetramer is obviated, but the method kills the cells. It is
 
possible to combine the two techniques, double staining
cells with tetramer and anti–IFN-
 
g
 
, after peptide stimula-
tion, brefeldin treatment, and permeabilization (16). The
IFN-
 
g
 
 ELIspot assay for peptide-stimulated cells gives sim-
ilar results and is efficient at detecting low numbers, for in-
stance, influenza virus–specific responses, long after the vi-
rus has departed (24).
Real questions are posed about the value of the LDA.
The numbers of precursors detected by LDA are often 50–
500 times lower than those detected by the other methods
(10). Does this mean the LDA is worthless? One possible
explanation is that only a minority of the cloned T cells can
actually kill; however, functional assays on sorted tetramer-
binding cells argue against this. Another major difference
between the LDA and the direct detection assays, such as
tetramer staining, is that the LDA depends on cell division.
In the informative range of the assay, each microtiter tray
well should contain one clone. To detect a cytolytic re-
sponse, measurable killing is needed, often 10% specific ly-
sis. CTL clone data indicate that this would need an effec-
tor/target ratio of 
 
z
 
0.5:1; using 4 
 
3 
 
10
 
3
 
 target cells, 2 
 
3
 
10
 
3
 
 CTLs would be needed in the wells to score positive,
i.e., 11 divisions from a single precursor. Bulk culture as-
says, which are semiquantitative, need a similar number of
divisions. Therefore, the low number of T cells detected in
acute virus infection indicates that only a minority of anti-
gen-specific T cells, 
 
,
 
1%, have made this number of divi-
sions in vitro. In acute infections, most of the expanded
CTLs are destined to die by apoptosis; this may also be true
of the T cells activated at a lower level by persisting virus.
Only when the virus has been gone for some time (years in
humans) do the LDA and tetramer assays come close (23).
The LDA may therefore give a meaningful figure of T cells
with long-term growth potential. Subtle differences in the
strength of signal given by the TCR and accessory mole-
cules could determine the rate of growth such that only
those receiving the strongest signal show up in the LDA.
However the assay is beset by technical difficulties and as-
sumptions about the cutoff. The LDA needs careful reas-
sessment in the light of these recent findings.
The differences between the numbers obtained by the
different assays could be reconciled as shown in Fig. 2.
There is a problem of terminology: Should T cells be de-
scribed by their function or antigen binding properties? Al-
though there is agreement between tetramer staining and
staining for IFN-
 
g
 
, it is harder to show that all the detected
cells can kill. Nevertheless, the term effector CTL (eCTL)
is used to describe expanded CD8
 
1
 
 antigen-binding T cells
that have limited growth potential (in vitro, at least); they
are assumed to have some effector function such as lysis,
cytokine release, or both, but it is recognized that some T
cells in this category could be exhausted. Gallimore et al.
(16) showed that in some situations where there is exces-
sive antigen, antigen-specific T cells can be detectable using
tetramers, although these cells exhibited a diminished ca-
pacity to produce IFN-
 
g
 
 and lytic activity in vitro. Thus,
quantitation of antigen-specific cells may not always accurately
reflect the antiviral potential of the expanded population. 
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Effector CTLs are fas-positive and likely to die by apop-
tosis. The term precursor CTL (pCTL) is used in Fig. 2 
 
A
 
to describe only those T cells, detected by LDA, with
growth potential. It is possible that there is a continuum of
expanded cells having a growth potential of between 0 and
25 or more divisions; if so, the eCTL and pCTL categories
would refer only to the extremes (Fig. 2 
 
B
 
). However, this
model would predict that the acute immune response and
long-term memory response might have quite different
clonal composition and even different specificities. The
data collected so far suggest the opposite (10, 14, 15, 20,
25).
CTL clones that have not yet made contact with antigen
would be described as naive CTLs (nCTLs). Both eCTLs
and pCTLs belong to the memory pool. However, it could
be argued that only those with true long-term growth po-
tential are the true memory cells, the cells that can survive
long after antigen has gone. The differences between
nCTLs and pCTLs include their absolute numbers and ex-
pression of certain surface glycoproteins such as CD45 iso-
mers. The growth potential of some naive T cells is very
impressive. It is curious that it is so difficult to reproduce
this in vitro, but with possible exceptions (26). Primary
CTL responses in vitro have not been easily obtained and it
may take several weeks to culture rather poorly growing
clones. The findings of these recent papers should spur ef-
forts to stimulate rapid massive CTL responses in vitro. At-
tention needs to be paid to the epitope chosen as well as
the antigen-presenting cells, probably dendritic cells, the
local environment, and the cytokine milieu required.
Finally, Are these very large primary CD8
 
1
 
 T cell re-
sponses necessary or is there an overreaction? For persistent
HIV infection, Ogg et al. have shown an inverse correla-
tion between the level of tetramer positive CD8 T cells and
virus load (13). In the systemic infections studied, the num-
ber of virus-infected cells must be very high. The ratio of
reactive T cells to infected target cell would be expected to
favor lysis of infected cells before they release new virus
particles (27). A degree of overresponse, provided it is con-
trolled by apoptosis, may well be advantageous; it is reas-
suring that CD8
 
1
 
 T cell malignancies are rare. These com-
mon massive T cell expansions must be well managed.
 
References
 
1. Matsui, K., J.J. Boniface, P. Steffner, P.A. Reay, and M.M.
Davis. 1994. Kinetics of T-cell receptor binding to peptide/I-
Ek complexes: correlation of the dissociation rate with T-cell re-
sponsiveness. 
 
Proc. Natl. Acad. Sci. USA.
 
 91:12862–12866.
2. Valitutti, S., S. Muller, M. Cella, E. Padoven, and A. Lanza-
vecchia. 1995. Serial triggering of many T-cell receptors by a
few peptide–MHC complexes. 
 
Nature.
 
 375:148–151.
3. McHeyzer-Williams, M.G., J.D. Altman, and M.M. Davis.
1996. Enumeration and characterization of memory cells in
the TH compartment.
 
 Immunol. Rev.
 
 150:5–21.
4. Reid, S.W., S. McAdam, K.J. Smith, P. Klenerman, C.A.
O’Callaghan, K. Harlos, B.K. Jakobsen, A.J. McMichael, J.I.
 
Address correspondence to Andrew J. McMichael, Institute of Molecular Medicine, Nuffield Department of
Medicine, John Radcliffe Hospital, Oxford OX3 9DS, United Kingdom. Phone: 44-1865-222336; Fax: 44-
1865-222502; E-mail: andrew.mcmichael@ndm.ox.ac.uk
 
Received for publication on 16 March 1998.
Figure 2. (A) Scheme of the life history of CTL clones specific for a
single epitope. nCTLs are rapidly triggered by primary virus infection to
generate very large numbers of effector eCTLs that are functional but
doomed to die by apoptosis. A small subpopulation takes an alternative
route and maintains their growth potential; these pCTLs are detectable by
LDA and carry long-term memory. (B) Alternative scheme for the life
history of CTLs. On contact with antigen, CTLs proliferate at different
rates. At the extremes, greatly expanded eCTLs apoptose and those that
proliferated very little persist as long-term memory cells. Many cells fall in
between. This model predicts that the clonal composition of eCTLs and
pCTLs would be different. A theoretical problem with this model is that
cells that divide poorly in the primary response have the greatest growth
potential and have to give rise to rapidly dividing daughter cells on rein-
fection. 
1371
 
McMichael and O’Callaghan
Bell, D.I. Stuart, and E.Y. Jones. 1996. Antagonist HIV-1
Gag peptides induce structural changes in HLA B8. 
 
J. Exp.
Med.
 
 184:2279–2286.
5. Altman, J., P.A.H. Moss, P. Goulder, D. Barouch, M.
McHeyzer-Williams, J.I. Bell, A.J. McMichael, and M.M.
Davis. 1996. Direct visualization and phenotypic analysis of
virus-specific T lymphocytes in HIV-infected individuals.
 
Science.
 
 274:94–96.
6. Carmichael, A., X. Jin, P. Sissons, and L. Borysiewicz. 1993.
Quantitative analysis of the human immunodeficiency virus
type 1 (HIV-1)–specific cytotoxic T lymphocyte (CTL) re-
sponse at different stages of HIV-1 infection: differential CTL
responses to HIV-1 and Epstein-Barr virus in late disease.
 
 J.
Exp. Med.
 
 177:249–256.
7. Gotch, F.M., D.F. Nixon, N. Alp, A.J. McMichael, and L.K.
Borysiewicz. 1990. High frequency of memory and effector
gag specific cytotoxic T lymphocytes in HIV seropositive in-
dividuals. 
 
Int. Immunol.
 
 2:707–712.
8. Moss, P.A.H., S.L. Rowland-Jones, P.M. Frodsham, S.
McAdam, P. Giangrande, A.J. McMichael, and J.I. Bell.
1995. Persistent high frequency of human immunodeficiency
virus–specific cytotoxic T cells in peripheral blood of infected
donors. 
 
Proc. Natl. Acad. Sci. USA.
 
 92:5773–5777.
9. Kalams, S.A., R.P. Johnson, A.K. Trocha, M.J. Dynan, H.S.
Ngo, R.T. D’Aquila, J.T. Kurnick, and B.D. Walker. 1994.
Longitudinal analysis of T cell receptor (TCR) gene usage by
human immunodeficiency virus 1 envelope-specific cyto-
toxic T lymphocyte clones reveals a limited TCR repertoire.
 
J. Exp. Med.
 
 179:1261–1271.
10. Kuroda, M.J., J.E. Schmitz, D.H. Barouch, A. Craiu, T.M.
Allen, A. Sette, D.I. Watkins, M.A. Forman, and N.L.
Letvin. 1998. Analysis of gag-specific cytotoxic T lympho-
cytes in SIV mac-infected rhesus monkeys by cell staining
with a tetrameric MHC class I–peptide complex. 
 
J. Exp.
Med.
 
 187:1373–1381.
11. Chen, Z.W., Z.C. Kou, C. Lekutis, L. Shen, D. Zhou, M.
Halloran, J. Li, J. Sodroski, D. Lee-Parritz, and N.L. Letvin.
1995. T cell receptor V
 
b
 
 repertoire in an acute infection of
rhesus monkeys with simian immunodeficiency viruses and a
chimeric simian-human immunodeficiency virus. 
 
J. Exp.
Med.
 
 182:21–31.
12. Pantaleo, G., J.F. Demarest, H. Soudeyns, C. Graziosi, F.
Denis, J.W. Adelsberger, P. Borrow, M.S. Saag, G.M. Shaw,
R.P. Sekaly, and A.S. Fauci. 1994. Major expansion of
CD8
 
1
 
 T cells with a predominant V beta usage during the
primary immune response to HIV. 
 
Nature.
 
 370:463–467.
13. Ogg, G.S., X. Jin, S. Bonhoeffer, P.R. Dunbar, M.A.
Nowak, S. Monard, J.P. Segal, Y. Cao, S.L. Rowland-Jones,
V. Cerundolo, et al. 1998. Quantitation of HIV-1 specific
cytotoxic T lymphocytes and plasma load of viral RNA. 
 
Sci-
ence.
 
 279:2103–2106.
14. Butz, E.A., and M.J. Bevan. 1998. Massive expansion of anti-
gen-specific CD8
 
1
 
 T cells during an acute virus infection.
 
Immunity.
 
 8:167–175.
15. Murali-Krishna, K., J.D. Altman, M. Suresh, D.J.D. Sour-
dive, A.J. Zajac, J.D. Miller, J. Slansky, and R. Ahmed. 1998.
Counting antigen-specific CD8 T cells: a reevaluation of by-
stander activation during viral infection. 
 
Immunity.
 
 8:177–187.
16. Gallimore, A., A. Glithero, A. Godkin, A. Tissot, A. Althage,
A. Pluckthun, T. Elliott, H. Hengartner, and R. Zinkerna-
gel. 1998. Induction and exhaustion of lymphocytic chori-
omeningitis virus–specific cytotoxic T lymphocytes visualized
using soluble tetrameric MHC class I–peptide complexes. 
 
J.
Exp. Med.
 
 187:1383–1393.
17. Ehl, S., J. Hombach, P. Aichele, H. Hengartner, and R.M.
Zinkernagel. 1997. Bystander activation of cytotoxic T cells:
studies on the mechanism and evaluation of in vivo signifi-
cance in a transgenic mouse model. 
 
J. Exp. Med.
 
 185:1241–
1251.
18. Callan, M.F.C., N. Steven, P. Krausa, P.A.H. Moss, J.D.K.
Wilson, J.I. Bell, A.B. Rickinson, and A.J. McMichael. 1996.
Large clonal expansions of CD8
 
1
 
 T cells in acute infectious
mononucleosis. 
 
Nat. Med.
 
 2:906–911.
19. Callan, M.F., L. Tan, N. Annels, G.S. Ogg, J. Wilson, C.A.
O’Callaghan, A.J. McMichael, and A.B. Rickinson. 1998.
Direct visualization of antigen specific CD8
 
1
 
 T cells during
the primary immune response to Epstein Barr virus in vivo. 
 
J.
Exp. Med.
 
 187:1395–1402.
20. Busch, D.H., I.M. Pilip, S. Vijh, and E.G. Pamer. 1998. Co-
ordinate regulation of complex T cell populations responding
to bacterial infection. 
 
Immunity.
 
 In press.
21. Deckhut, A.M., W. Allan, A. McMickle, M. Eichelberger,
M.A. Blackman, P.C. Doherty, and D.L. Woodland. 1993.
Prominent usage of V beta 8.3 T cells in the H-2Db–restricted
response to an influenza A virus nucleoprotein epitope. 
 
J. Im-
munol.
 
 151:2658–2663.
22. Tough, D.F., and J. Sprent. 1996. Viruses and T cell turn-
over: evidence for bystander proliferation. 
 
Immunol. Rev.
 
 150:
129–142.
23. Dunbar, P.R., G.S. Ogg, J. Chen, N. Rust, P. van der
Bruggen, and V. Cerundolo. 1998. Direct isolation, pheno-
typing and cloning of low-frequency antigen-specific cyto-
toxic T lymphocytes from peripheral blood. 
 
Curr. Biol.
 
 In
press.
24. Lalvani, A., R. Brookes, S. Hambleton, W.J. Britton, A.V.
Hill, and A.J. McMichael. 1997. Rapid effector function in
CD8
 
1
 
 
 
memory T cells. 
 
J. Exp. Med.
 
 186:859–865.
25. Silins, S.L., S.M. Cross, S.L. Elliott, S.J. Pye, S.R. Burrows,
J.M. Burrows, D.J. Moss, V.P. Argaet, and I.S. Misko. 1996.
Development of Epstein-Barr virus–specific memory T cell
receptor clonotypes in acute infectious mononucleosis. 
 
J.
Exp. Med.
 
 184:1815–1824.
26. Macatonia, S.E., P.M. Taylor, S.C. Knight, and B.A. Asko-
nas. 1989. Primary stimulation by dendritic cells induces anti-
viral proliferative and cytotoxic T cell responses in vitro. 
 
J.
Exp. Med. 
 
169:1255–1264.
27. Klenerman, P., R.E. Phillips, C.R. Rinaldo, L.M. Wahl, G.
Ogg, R.M. May, A.J. McMichael, and M.A. Nowak. 1996.
Cytotoxic T lymphocytes and viral turnover in HIV type 1
infection. 
 
Proc. Natl. Acad. Sci. USA
 
. 93:15323–15328.